- Home
- H vs SNN Comparison
H vs SNN Comparison
Compare H & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | H | SNN |
|---|---|---|
| Founded | 1957 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Hotels/Resorts | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6B | 14.3B |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | H | SNN |
|---|---|---|
| Price | $164.37 | $32.20 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 2 |
| Target Price | ★ $179.53 | $36.25 |
| AVG Volume (30 Days) | 676.7K | ★ 900.0K |
| Earning Date | 04-30-2026 | 03-16-2026 |
| Dividend Yield | 0.37% | ★ 2.38% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,685,000,000.00 | N/A |
| Revenue This Year | $110.63 | $8.58 |
| Revenue Next Year | $7.01 | $5.60 |
| P/E Ratio | ★ N/A | $64.97 |
| Revenue Growth | ★ 5.78 | N/A |
| 52 Week Low | $108.24 | $26.58 |
| 52 Week High | $180.53 | $38.79 |
Technical Indicators
Market Signals| Indicator | H | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 58.13 | 43.24 |
| Support Level | $137.21 | $32.03 |
| Resistance Level | $171.80 | $32.22 |
| Average True Range (ATR) | 5.39 | 0.57 |
| MACD | 0.69 | -0.13 |
| Stochastic Oscillator | 55.54 | 27.75 |
Price Performance
Historical ComparisonAbout H Hyatt Hotels Corporation
Hyatt is an operator of owned (2% of total rooms) and managed and franchised (98%) properties across about 35 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva, and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, the wellness brand Miraval, and the midscale extended-stay brand Studios. Hyatt acquired Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 45% for the US, 31% rest of world, and 24% Asia-Pacific.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.